Noninvasive Parametric Blood Flow Imaging of Head and Neck Tumours Using [15O]H2O and PET/CT
Overview
Affiliations
Purpose: The aim of this study was to develop a simple noninvasive method for measuring blood flow using [15O]H2O PET/CT for the head and neck area applicable in daily clinical practice.
Patients And Methods: Fifteen dynamic [15O]H2O PET emission scans with simultaneous online radioactivity measurements of radial arterial blood [Blood-input functions (IFs)] were performed. Two noninvasively obtained population-based input functions were calculated by averaging all Blood-IF curves corrected for patients' body mass and injected dose [standardized uptake value (SUV)-IF] and for body surface area (BSA-IF) and injected dose. Parametric perfusion images were calculated for each set of IFs using a linearized two-compartment model, and values for several tissues were compared using Blood-IF as the gold standard.
Results: On comparing all tissues, the correlation between blood flow obtained with the invasive Blood-IF and both SUV-IF and BSA-IF was significant (R2=0.785 with P<0.001 and R2=0.813 with P<0.001, respectively). In individual tissues, the performance of the two noninvasive methods was most reliable in resting muscle and slightly less reliable in tumour and cerebellar regions. In these two tissues, only BSA-IF showed a significant correlation with Blood-IF (R2=0.307 with P=0.032 in tumours and R2=0.398 with P<0.007 in the cerebellum).
Conclusion: The BSA-based noninvasive method enables clinically relevant delineation between areas of low and high blood flow in tumours. The blood flow of low-perfusion tissues can be reliably quantified using either of the evaluated noninvasive methods.
Jochumsen M, Christensen N, Iversen P, Gormsen L, Sorensen J, Tolbod L Eur J Nucl Med Mol Imaging. 2024; 51(13):4134-4140.
PMID: 38940842 PMC: 11527927. DOI: 10.1007/s00259-024-06799-3.
Non-invasive quantification of tumor blood flow in prostate cancer using O-HO PET/CT.
Tolbod L, Nielsen M, Pedersen B, Hoyer S, Harms H, Borre M Am J Nucl Med Mol Imaging. 2018; 8(5):292-302.
PMID: 30510847 PMC: 6261877.
Lahesmaa M, Oikonen V, Helin S, Luoto P, U Din M, Pfeifer A Eur J Nucl Med Mol Imaging. 2018; 46(3):743-750.
PMID: 30105585 PMC: 6351510. DOI: 10.1007/s00259-018-4120-2.
Cammaroto G, Quartuccio N, Sindoni A, Di Mauro F, Caobelli F Eur Arch Otorhinolaryngol. 2015; 273(8):1961-73.
PMID: 25971995 DOI: 10.1007/s00405-015-3651-4.
Komar G, Lehtio K, Seppanen M, Eskola O, Levola H, Lindholm P Eur J Nucl Med Mol Imaging. 2014; 41(11):2042-50.
PMID: 24898846 DOI: 10.1007/s00259-014-2818-3.